Cargando…
Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma
OBJECTIVE: MicroRNA (miR)-22 plays crucial roles in malignant tumors and is involved in regulation of chemosensitivity. Additionally, altered expression of circulating miR-22 has been reported in various cancers. This study was designed to investigate plasma miR-22 expression in patients with osteos...
Autores principales: | Diao, Zhen-bin, Sun, Tian-xiao, Zong, Yi, Lin, Bo-chuan, Xia, Yuan-sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724422/ https://www.ncbi.nlm.nih.gov/pubmed/33284712 http://dx.doi.org/10.1177/0300060520967818 |
Ejemplares similares
-
MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma
por: Liu, Wei, et al.
Publicado: (2017) -
MicroRNA-22-3p alleviates atherosclerosis by mediating macrophage M2 polarization as well as inhibiting NLRP3 activation
por: Bian, Xiaoyan, et al.
Publicado: (2023) -
MicroRNA-22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma
por: Meng, Chen-Yang, et al.
Publicado: (2020) -
Circular RNA SMARCA5 inhibits cholangiocarcinoma via microRNA-95-3p/tumor necrosis factor receptor associated factor 3 axis
por: Wang, Guangxin, et al.
Publicado: (2023) -
MicroRNA-340 is involved in ultraviolet B-induced pigmentation by regulating the MITF/TYRP1 axis
por: Yang, Yi, et al.
Publicado: (2020)